Neuroaspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid

13Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Aspergillosis of the central nervous system (CNS) is an uncommon infection, mainly occurring in immunocompromised patients. We report a case of nasocerebral aspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid. Magnetic resonance imaging (MRI) showed contrast enhancement surrounding the brainstem and cerebellum with intramedullary pontine and cerebellar T2-hyperintense lesions. The patient's symptoms and MRI abnormalities improved after voriconazole and corticosteroid treatment; however, discontinuation of the corticosteroid caused a worsening of the T2-hyperintense lesions, whereas resuming it resulted in its improvement. This suggested that these T2-hyperintense lesions may be due to secondary inflammation caused by aspergillosis and not the aspergillosis itself. We conclude that treatment with a combination of voriconazole and a corticosteroid appears to be effective for the treatment of some patients with CNS aspergillosis. © 2009 The Japanese Society of Internal Medicine.

Author supplied keywords

Cite

CITATION STYLE

APA

Hiraga, A., Uzawa, A., Shibuya, M., Numata, T., Sunami, S., & Kamitsukasa, I. (2009). Neuroaspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid. Internal Medicine, 48(14), 1225–1229. https://doi.org/10.2169/internalmedicine.48.2165

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free